ArticleNature biotechnology2025

In vivo AAV-SB-CRISPR screens of tumor-infiltrating primary NK cells identify genetic checkpoints of CAR-NK therapy.

Lei Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.